14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
BGMSP vs CVM: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Cel-Sci Corporation (CVM) is the stronger overall head-to-head candidate over BGMSP (BGMSP) in the Tradestie Institutional Equity Comparison Engine, winning 10–0 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). BGMSP carries a Unified Composite Score of 42.7/100 (HOLD) at $1.44 (N/M Forward P/E, N/A operating margin), whereas CVM carries 56.6/100 (HOLD) at $1.59 (23.0x Forward P/E, 0.0% operating margin).
Technical & Structure Timing Caution: BGMSP trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI N/A); meanwhile CVM is in a Breakdown options structure phase (RSI 57.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BGMSP vs CVM. Trailing 12-month operating profitability (BGMSP N/A vs CVM 0.0%) and valuation multiples (BGMSP N/M vs CVM 23.0x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Biotechnology value chain with $20.9M market capitalization and 0.0% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ BGMSP vs CVM Key Questions & Quantitative Answers
As of Nov 16, 2026, Cel-Sci Corporation (CVM) is the stronger overall head-to-head candidate over BGMSP (BGMSP) in the Tradestie Institutional Equity Comparison Engine, winning 10–0 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). BGMSP carries a Unified Composite Score of 42.7/100 (HOLD) at $1.44 (N/M Forward P/E, N/A operating margin), whereas CVM carries 56.6/100 (HOLD) at $1.59 (23.0x Forward P/E, 0.0% operating margin). Technical & Structure Timing Caution: BGMSP trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI N/A); meanwhile CVM is in a Breakdown options structure phase (RSI 57.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
CVM leads the Growth & Scale pillar: BGMSP posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with CVM at -62.7% YoY revenue growth and +0.0% YoY earnings growth on $28,558 TTM revenue (N/A gross margin, 0.0% operating margin). On trailing 12-month operating scale, BGMSP generates N/A in USD-normalized revenue versus $28,558 for CVM. In operating R&D and SG&A reinvestment, BGMSP deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for CVM.
CVM screens cheaper on headline valuation multiples. BGMSP trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas CVM trades at 23.0x Forward P/E, 23.0x Trailing P/E, 1.12x PEG, and N/M EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against BGMSP (N/A ROE) versus CVM (-252.5% ROE) capital efficiency.
In options market volatility and institutional positioning, BGMSP carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.59β · 201% Vol realized risk). By comparison, CVM carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (0.65β · 120% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.